65 related articles for article (PubMed ID: 24383078)
1. Lecithin cholesterol acyltransferase (LCAT) activity in the presence of Apo-AI-derived peptides exposed to disorder-order conformational transitions.
Aguilar-Espinosa SL; Mendoza-Espinosa P; Delgado-Coello B; Mas-Oliva J
Biochem Biophys Res Commun; 2013 Nov; 441(2):469-75. PubMed ID: 24383078
[TBL] [Abstract][Full Text] [Related]
2. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
[TBL] [Abstract][Full Text] [Related]
3. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions.
Rogers DP; Roberts LM; Lebowitz J; Datta G; Anantharamaiah GM; Engler JA; Brouillette CG
Biochemistry; 1998 Aug; 37(34):11714-25. PubMed ID: 9718294
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
[TBL] [Abstract][Full Text] [Related]
5. Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides.
Casteleijn MG; Parkkila P; Viitala T; Koivuniemi A
J Lipid Res; 2018 Apr; 59(4):670-683. PubMed ID: 29438987
[TBL] [Abstract][Full Text] [Related]
6. Structural studies of a peptide activator of human lecithin-cholesterol acyltransferase.
Buchko GW; Treleaven WD; Dunne SJ; Tracey AS; Cushley RJ
J Biol Chem; 1996 Feb; 271(6):3039-45. PubMed ID: 8621698
[TBL] [Abstract][Full Text] [Related]
7. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
8. Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation.
Rogers DP; Brouillette CG; Engler JA; Tendian SW; Roberts L; Mishra VK; Anantharamaiah GM; Lund-Katz S; Phillips MC; Ray MJ
Biochemistry; 1997 Jan; 36(2):288-300. PubMed ID: 9003180
[TBL] [Abstract][Full Text] [Related]
9. LCAT activation properties of apo A-I CNBr fragments and conversion of discoidal complexes into spherical particles.
Vanloo B; Taveirne J; Baert J; Lorent G; Lins L; Ruyschaert JM; Rosseneu M
Biochim Biophys Acta; 1992 Oct; 1128(2-3):258-66. PubMed ID: 1420299
[TBL] [Abstract][Full Text] [Related]
10. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
Hine D; Mackness B; Mackness M
IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096
[TBL] [Abstract][Full Text] [Related]
11. An approach to the functional analysis of lecithin-cholesterol acyltransferase. Activation by recombinant normal and mutagenized apolipoprotein AI.
Bruhn H; Stoffel W
Biol Chem Hoppe Seyler; 1991 Mar; 372(3):225-34. PubMed ID: 1905134
[TBL] [Abstract][Full Text] [Related]
12. Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation.
Mazière JC; Myara I; Salmon S; Auclair M; Haigle J; Santus R; Mazière C
Atherosclerosis; 1993 Dec; 104(1-2):213-9. PubMed ID: 8141845
[TBL] [Abstract][Full Text] [Related]
13. Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family.
Idzior-Waluś B; Sieradzki J; Kostner G; Małecki MT; Klupa T; Wesołowska T; Rostworowski W; Hartwich J; Waluś M; Kieć AD; Naruszewicz M
Atherosclerosis; 2006 Apr; 185(2):413-20. PubMed ID: 16051254
[TBL] [Abstract][Full Text] [Related]
14. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP
Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091
[TBL] [Abstract][Full Text] [Related]
15. Systematic evaluation of lecithin:cholesterol acyltransferase binding sites in apolipoproteins via peptide based nanodiscs: regulatory role of charged residues at positions 4 and 7.
Niemelä A; Koivuniemi A
PLoS Comput Biol; 2024 May; 20(5):e1012137. PubMed ID: 38805510
[TBL] [Abstract][Full Text] [Related]
16. Branched synthetic peptide constructs mimic cellular binding and efflux of apolipoprotein AI in reconstituted high density lipoproteins.
Nion S; Demoor L; Boutillon C; Luchoomun J; Vanloo B; Fievet C; Castro G; Rosseneu M; Fruchart JC; Tartar A; Clavey V
Atherosclerosis; 1998 Dec; 141(2):227-35. PubMed ID: 9862171
[TBL] [Abstract][Full Text] [Related]
17. Measurement of lecithin-cholesterol acyltransferase activity with the use of a Peptide-proteoliposome substrate.
Vaisman BL; Remaley AT
Methods Mol Biol; 2013; 1027():343-52. PubMed ID: 23912995
[TBL] [Abstract][Full Text] [Related]
18. Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.
Wong L; Curtiss LK; Huang J; Mann CJ; Maldonado B; Roheim PS
J Clin Invest; 1992 Dec; 90(6):2370-5. PubMed ID: 1281832
[TBL] [Abstract][Full Text] [Related]
19. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
[TBL] [Abstract][Full Text] [Related]
20. Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides.
Subbarao NK; Fielding CJ; Hamilton RL; Szoka FC
Proteins; 1988; 3(3):187-98. PubMed ID: 3255105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
